National Jewish Health Adult Cystic Fibrosis Clinic

Home
United States
Denver, CO
National Jewish Health Adult Cystic Fibrosis Clinic

The National Jewish Health Adult Cystic Fibrosis Clinic is the largest CF center in the United States, following nearly 300 adults.

The National Jewish Health Adult Cystic Fibrosis page is intended to provide our patients, their families and support systems, updates about our clinic and other helpful information. We are part of the National Therapeutics Development Network (TDN), a network of nearly 80 CF clinical research centers dedicated to conducting clinical trials in order to evaluate the safety and effectiveness of new CF therapies. As CF is a multi-organ system disease affecting the lives of both the patient and his/her family, our CF team includes the following healthcare professionals: Pulmonary Physicians, Nurse Coordinators, Respiratory Therapist, Endocrinologist, Registered Dietitian, Social Workers, and Research Coordinators. Description
Social Media Guidelines & Comment Policy: http://www.nationaljewish.org/about/mediacenter/social-media/

General Information
National Jewish Health is an Affirmative Action/Equal Opportunity Employer, and we are committed to hiring a diverse and talented workforce. EOE/AA/M/F/Disabled/Vet/ Tobacco Free Campus.

03/08/2026

Could a wrinkle on your ear be a sign of disease? Cardiologist Andrew Freeman, MD, comments on an intriguing theory in this story by TODAY.

In TODAY.com's Expert Tip of the Day, a cardiologist weighs in on "Frank's sign," a subtle feature on a specific body part that may predict your risk of underlying heart disease.

02/13/2026

Happy Valentine's Day from the CF Team!

01/14/2026

Happy 2026! Here is a helpful resource for getting back into exercising. Learn more here: https://brnw.ch/21wZ5Yr

12/17/2025

Happy Holidays!

11/09/2025

Today we welcome neurologist Joshua Nardin, DO, to our team. Dr. Nardin specializes in neuromuscular disorders and electrodiagnostic medicine, providing care for patients with conditions affecting and , such as amyotrophic lateral sclerosis ( ). Learn more:

Joshua A. Nardin, DO, has joined National Jewish Health as a neurologist specializing in neuromuscular disorders and electrodiagnostic medicine. He provides comprehensive care for patients with conditions affecting nerves and muscles, including neuropathies, myopathies, myasthenia gravis, amyotrophi...

11/08/2025

Today is National Lung Cancer Screening Day!
We’re proud to be one of hundreds of screening centers nationwide offering this special Saturday event. Our dedicated team volunteered their time to raise awareness about the importance of lung cancer screening — and to help save lives through early detection. This lifesaving screening is covered by most insurance for people ages 50–80 who currently smoke or quit within the past 15 years and have a 20 pack-year smoking history or more. Call 303.270.2551 today to schedule your appointment.

07/08/2025

Here's a free webinar with our own Jennifer Taylor-Cousar, MD, and other panelists.
● Learn about the most promising advances in genetic therapies (for those who don't benefit from current CFTR modulators).
● Get candid insights on scientific hurdles, delivery strategies and what’s next.
● Participate in a live Q and A.

Registration is required. Use the link below.
https://www.emilysentourage.org/post-symposium-webinar-2025/

05/07/2025

Our care team is proud to wear purple in honor of Cystic Fibrosis Awareness Month this May. Together, we stand with the CF community in support, strength and hope. 💜

03/17/2025

Here's an opportunity for CF patients to provide input.

01/08/2025

Happy New Year!
As many of you have heard, there is a new combination CFTR modulator drug recently approved by the FDA called ALYFTREK (TM). For those of you who were not previously eligible for a modulator, but now are eligible, we will reach out to you individually to schedule an appointment to discuss initiating therapy.

For those of you who are already on TRIKAFTA®, the new drug is expected to be very similar in benefit as TRIKAFTA (e.g. based on the clinical trials, we do not expect your lung function to improve further), but ALYFTREK will be dosed once daily. In the clinical trials, side effects for ALYFTREK were similar to the ones reported in the TRIKAFTA trials. It is not yet known if people who did not tolerate TRIKAFTA will be able to tolerate ALYFTREK better.

ALYFTREK will be available in some pharmacies in the next few weeks but may take longer in other cases. ALYFTREK is expected to be more expensive than TRIKAFTA, and we do not yet know which insurance plans will allow patients to switch if they are currently doing well on TRIKAFTA. We expect that many people with CF that are doing well on TRIKAFTA will wish to continue their current therapy, and that others would be interested in trying ALYFTREK. We are happy to discuss these options with you at your next visit.

For those of you who are not eligible for any CFTR modulators, we are continuing to do research to find a drug that will help you. Please reach out to your doctor or to the research team if you would like to participate in a clinical trial.

Best wishes
The Colorado Adult CF Program Team

12/18/2024

Happy Holidays 🎄🎄! Wishing you peace and health.
❤️ your CF team

05/08/2024

The adult CF careteam bringing awareness to cystic fibrosis this month. Today and everyday we honor our patients and their families 💜

Address

1400 Jackson Street
Denver, CO
80206

Telephone

+13032702333

Website

http://www.nationaljewish.org/programs/directory/cystic-fibrosis/

Alerts

Be the first to know and let us send you an email when National Jewish Health Adult Cystic Fibrosis Clinic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Denver?